ImmunityBio (IBRX) Deferred Taxes (2016 - 2021)
ImmunityBio (IBRX) posted quarterly Deferred Taxes of -$8000.0 for Q4 2021, up 96.14% year-over-year from -$4078.8 in Q4 2020, and up 96.14% quarter-over-quarter from -$207000.0 in Q4 2020.
ImmunityBio (IBRX) Deferred Taxes (2016 - 2021) Analysis & Trends
ImmunityBio (IBRX) has reported Deferred Taxes for 6 consecutive years, with -$8000.0 the latest figure, recorded in Q4 2021.
- In Q4 2021, Deferred Taxes rose 96.14% year-over-year to -$8000.0; the TTM figure through Dec 2021 stood at -$8000.0 (up 99.73% YoY), while the FY2022 annual figure was -$4000.0, up 50.0% from the prior year.
- Deferred Taxes grew to -$8000.0 in Q4 2021 per IBRX's latest filing, from -$207000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $38000.0 in Q2 2020 and bottomed at -$1.7 million in Q3 2020.
- Historically, Deferred Taxes has averaged -$282071.4 across 5 years, with a median of -$124000.0 in 2017.
- Annual changes were most pronounced in 2020 — Deferred Taxes sank 2487.5% — and 2021, when it jumped 96.14%.
- ImmunityBio's Deferred Taxes stood at -$182000.0 in 2017, then jumped by 32.97% to -$122000.0 in 2018, then jumped by 93.44% to -$8000.0 in 2019, then tumbled by 2487.5% to -$207000.0 in 2020, then surged by 96.14% to -$8000.0 in 2021.
- Business Quant data shows IBRX's Deferred Taxes at -$8000.0 in Q4 2021, -$207000.0 in Q4 2020, and -$1.7 million in Q3 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -137,876.64 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.66 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | ImmunityBio | 7.97 Bn | 7.62 Bn | 50.94 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -8,000.00 |
| Dec 31, 2020 | -207,000.00 |
| Sep 30, 2020 | -1.70 Mn |
| Jun 30, 2020 | 38,000.00 |
| Mar 31, 2020 | -1.07 Mn |
| Dec 31, 2019 | -8,000.00 |
| Dec 31, 2018 | -122,000.00 |
| Sep 30, 2018 | -128,000.00 |
| Jun 30, 2018 | -124,000.00 |
| Mar 31, 2018 | -124,000.00 |
| Dec 31, 2017 | -182,000.00 |
| Sep 30, 2017 | -98,000.00 |
| Jun 30, 2017 | -124,000.00 |
| Mar 31, 2017 | -93,000.00 |
| Dec 31, 2016 | -152,000.00 |
| Sep 30, 2016 | -50,000.00 |
| Jun 30, 2016 | -228,000.00 |
| Mar 31, 2016 | -145,000.00 |